1Ishii J,Cui W, Kitagawa F, et al. Prognostic value of combination of cardiac tropnin T and B type natriuretic peptide after initiation of treatment in patients with chronic heart failure [J]. Clin Chem, 2003,49(12) :2020-2026.
2Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure [J]. N Engl J Med, 2002,347(3) :161-167.
3Cherico A, Delry S, Gianmessi D, et al. Measurement of cardiac natriuretic hormones ( atrial natriuretic peptide, brain natriuretic peptide,and related peptides) in clinical practise: the need for a new generation of immunoassay methods [J]. Clin Chem,2000,46 (10) :15-17.
4Schinkel AF, Vourvouri EC, BaxJ J, et al. Relation between left ventricular contractile reserve during low dosed obutamine echo cardiography and plasma concentrations of natriuretie peptides [J]. Heart,2004,90(3) :293-296.
6Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B brain natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea [J]. J Am Coil Cardiol,2002,39(2):202-209.
7Krishnaswamy P, Lubien E, Clopton P, et al. Utility of B brain natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction [ J ]. Am J Med, 2001,111 (4) 274-279.
8Maisel AS, Krishnaswamy P, Nowak RN, et al. Rapid measurement of Prtype nutriuretic peptide in the emergency diagnosis of heart failure [J]. N Engl J Med,2002,347(3):161-167.
9Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction [J]. Circulation,1993,88(1) :82-91.
10Arakawa N, Nakamura M, Aoki H, et al. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size [J]. Cardiology, 1994,85(5) :334 340.
3Maisel A, E sphteyn V, Morrison K, et al. The use of B- natriuretic peptide in assessing cardiac function in patients with diabetesmellitus. Eur Heart Jour, 2001, 22: 494.
4Cabanes L, Richaud Thiriez B, Fulla Y, et al. Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea.Chest, 2001, 120. 2047-2050.
5Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol, 2002, 39:202-209.
6Wieczorek SJ, Bailly KR, Thomas P, et al. Clinical evaluation of the Triage(r) B-type natriuretic peptide assay for point of care testing of patients with congestive heart failure. Clinical Chemistry, 2000, 46: A77.
7Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New Engl J Med, 2002, 347: 161-167.
8Tabbibizar R, Maisel A. The impact of B-type natriuretic piptide levels on the diagnoses and management of congestive heart failure. Curr OpinCardiol, 2002, 17: 340-345.
9Maisel A. B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure. J Card Fail, 2001,7:183- 193.
10Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am CollCardiol, 2001, 37: 379-385.
10Ikonomidis I,Nikolaou M,Dimopoulou I,et al.Association of left ventricular diastolic dysfunction with elevated NT-pro-BNP in general intensive care unit patients with preserved ejection fraction:a complementary role of tissue doppler imaging parameters and NT-pro-BNP levels for adverse outcome[J].Shock,2010,33(2):141-148.
